Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuyuki Hosono

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cancer Cell|June 15, 2013
NKX2-1/TTF-1: an enigmatic oncogene that functions as a double-edged sword for cancer cell survival and progressionTomoya Yamaguchi, Yasuyuki Hosono, Kiyoshi Yanagisawa, et al.
Biochemical and Biophysical Research Communications|October 17, 2012
MYBPH inhibits NM IIA assembly via direct interaction with NMHC IIA and reduces cell motilityYasuyuki Hosono, Jiro Usukura, Tomoya Yamaguchi, et al.
JCO Precision Oncology|February 1, 2022
Evaluation of ALK Fusion Newly Identified in Colon Cancer by a Comprehensive Genomic AnalysisYasuyuki Hosono, Toshiki Masuishi, Seiichiro Mitani, et al.
Cancer Science|April 7, 2026
ROWVA: A Structure-Based Metric for Predicting the Pathogenicity of Protein Variants Using Alphafold2Taiki Furutani, Yuka Okusha, Hiroki Nagami, et al.
Plos One|June 21, 2011
A novel network profiling analysis reveals system changes in epithelial-mesenchymal transitionTeppei Shimamura, Seiya Imoto, Yukako Shimada, et al.
Oncogene|December 15, 2022
Long non-coding RNA TILR constitutively represses TP53 and apoptosis in lung cancerMika Iwai, Taisuke Kajino, Masahiro Nakatochi, et al.
Cancer Cell|March 24, 2012
NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinomaTomoya Yamaguchi, Kiyoshi Yanagisawa, Ryoji Sugiyama, et al.
Scientific Reports|August 11, 2016
Blood-borne miRNA profile-based diagnostic classifier for lung adenocarcinomaMei Chee Tai, Kiyoshi Yanagisawa, Masahiro Nakatochi, et al.
The EMBO Journal|November 17, 2011
MYBPH, a transcriptional target of TTF-1, inhibits ROCK1, and reduces cell motility and metastasisYasuyuki Hosono, Tomoya Yamaguchi, Eri Mizutani, et al.
Frontiers in Cell and Developmental Biology|February 4, 2022
Meclozine Attenuates the MARK Pathway in Mammalian Chondrocytes and Ameliorates FGF2-Induced Bone Hyperossification in Larval ZebrafishGenta Takemoto, Masaki Matsushita, Takaaki Okamoto, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cancer Cell|June 15, 2013
NKX2-1/TTF-1: an enigmatic oncogene that functions as a double-edged sword for cancer cell survival and progressionTomoya Yamaguchi, Yasuyuki Hosono, Kiyoshi Yanagisawa, et al.
Biochemical and Biophysical Research Communications|October 17, 2012
MYBPH inhibits NM IIA assembly via direct interaction with NMHC IIA and reduces cell motilityYasuyuki Hosono, Jiro Usukura, Tomoya Yamaguchi, et al.
JCO Precision Oncology|February 1, 2022
Evaluation of ALK Fusion Newly Identified in Colon Cancer by a Comprehensive Genomic AnalysisYasuyuki Hosono, Toshiki Masuishi, Seiichiro Mitani, et al.
Cancer Science|April 7, 2026
ROWVA: A Structure-Based Metric for Predicting the Pathogenicity of Protein Variants Using Alphafold2Taiki Furutani, Yuka Okusha, Hiroki Nagami, et al.
Plos One|June 21, 2011
A novel network profiling analysis reveals system changes in epithelial-mesenchymal transitionTeppei Shimamura, Seiya Imoto, Yukako Shimada, et al.
Oncogene|December 15, 2022
Long non-coding RNA TILR constitutively represses TP53 and apoptosis in lung cancerMika Iwai, Taisuke Kajino, Masahiro Nakatochi, et al.
Cancer Cell|March 24, 2012
NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinomaTomoya Yamaguchi, Kiyoshi Yanagisawa, Ryoji Sugiyama, et al.
Scientific Reports|August 11, 2016
Blood-borne miRNA profile-based diagnostic classifier for lung adenocarcinomaMei Chee Tai, Kiyoshi Yanagisawa, Masahiro Nakatochi, et al.
The EMBO Journal|November 17, 2011
MYBPH, a transcriptional target of TTF-1, inhibits ROCK1, and reduces cell motility and metastasisYasuyuki Hosono, Tomoya Yamaguchi, Eri Mizutani, et al.
Frontiers in Cell and Developmental Biology|February 4, 2022
Meclozine Attenuates the MARK Pathway in Mammalian Chondrocytes and Ameliorates FGF2-Induced Bone Hyperossification in Larval ZebrafishGenta Takemoto, Masaki Matsushita, Takaaki Okamoto, et al.
Pageof 3